Drug Interactions between cabergoline and Xanax
This report displays the potential drug interactions for the following 2 drugs:
- Xanax (alprazolam)
Interactions between your drugs
No interactions were found between cabergoline and Xanax. This does not necessarily mean no interactions exist. Always consult your healthcare provider.
- Cabergoline is in the drug class prolactin inhibitors.
- Cabergoline is used to treat Hyperprolactinemia.
- Xanax is in the drug class benzodiazepines.
- Xanax is used to treat the following conditions:
Drug and food interactions
Applies to: Xanax (alprazolam)
Grapefruit and grapefruit juice may interact with ALPRAZolam and lead to potentially dangerous side effects. Discuss the use of grapefruit products with your doctor. Do not increase or decrease the amount of grapefruit products in your diet without first talking to your doctor. Do not drink alcohol while taking ALPRAZolam. This medication can increase the effects of alcohol. You may feel more drowsy, dizzy, or tired if you take ALPRAZolam with alcohol. Talk to your doctor or pharmacist if you have any questions or concerns.
Applies to: cabergoline
Alcohol can increase the nervous system side effects of cabergoline such as dizziness, drowsiness, and difficulty concentrating. Some people may also experience impairment in thinking and judgment. You should avoid or limit the use of alcohol while being treated with cabergoline. Do not use more than the recommended dose of cabergoline, and avoid activities requiring mental alertness such as driving or operating hazardous machinery until you know how the medication affects you. Talk to your doctor or pharmacist if you have any questions or concerns.
Therapeutic duplication warnings
No warnings were found for your selected drugs.
Therapeutic duplication warnings are only returned when drugs within the same group exceed the recommended therapeutic duplication maximum.
Drug Interaction Classification
|Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.|
|Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.|
|Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.|
|No interaction information available.|